Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
Jialin Song et al, 2017, Front. Immunol. CrossRef
Potential Epigenetic-Based Therapeutic Targets for Glioma
Lanlan Zang et al, 2018, Front. Mol. Neurosci. CrossRef
Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics
Svetlana Miroshnichenko et al, 2019, Front. Pharmacol. CrossRef
MicroRNA profiling in the malignant progression of gliomas
E. V. Stupak et al, 2016 CrossRef
MicroRNA-221/222 Inhibits the Radiation-Induced Invasiveness and Promotes the Radiosensitivity of Malignant Meningioma Cells
Qing Zhang et al, 2020, Front. Oncol. CrossRef
The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression
Federica Caponnetto et al, 2020, Biomedicines CrossRef
MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies
Andrea Diana et al, 2020, IJMS CrossRef
Role of microRNAs in glioblastoma
Ming Chen et al, 2021, Oncotarget CrossRef
Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
Maria Mortoglou et al, 2021, Arch Toxicol CrossRef
Progress in research and development of temozolomide brain-targeted preparations: a review
Jiefen Yang et al, 2022, Journal of Drug Targeting CrossRef
Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy
Svetlana Gaponova et al, 2022, Cancers CrossRef
Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma.
Akram M Eraky, 2023, Cureus CrossRef
miRNA-targeting oligonucleotide constructs with various mechanisms of action as effective inhibitors of carcinogenesis
S. K. Miroshnichenko et al, 2024, Biological Products. Prevention, Diagnosis, Treatment CrossRef